Literature DB >> 24760766

Reactivation of maternal SNORD116 cluster via SETDB1 knockdown in Prader-Willi syndrome iPSCs.

Estela Cruvinel1, Tara Budinetz2, Noelle Germain3, Stormy Chamberlain3, Marc Lalande4, Kristen Martins-Taylor4.   

Abstract

Prader-Willi syndrome (PWS), a disorder of genomic imprinting, is characterized by neonatal hypotonia, hypogonadism, small hands and feet, hyperphagia and obesity in adulthood. PWS results from the loss of paternal copies of the cluster of SNORD116 C/D box snoRNAs and their host transcript, 116HG, on human chromosome 15q11-q13. We have investigated the mechanism of repression of the maternal SNORD116 cluster and 116HG. Here, we report that the zinc-finger protein ZNF274, in association with the histone H3 lysine 9 (H3K9) methyltransferase SETDB1, is part of a complex that binds to the silent maternal but not the active paternal alleles. Knockdown of SETDB1 in PWS-specific induced pluripotent cells (iPSCs) causes a decrease in the accumulation of H3K9 trimethylation (H3K9me3) at 116HG and corresponding accumulation of the active chromatin mark histone H3 lysine 4 dimethylation (H3K4me2). We also show that upon knockdown of SETDB1 in PWS-specific iPSCs, expression of maternally silenced 116HG RNA is partially restored. SETDB1 knockdown in PWS iPSCs also disrupts DNA methylation at the PWS-IC where a decrease in 5-methylcytosine is observed in association with a concomitant increase in 5-hydroxymethylcytosine. This observation suggests that the ZNF274/SETDB1 complex bound to the SNORD116 cluster may protect the PWS-IC from DNA demethylation during early development. Our findings reveal novel epigenetic mechanisms that function to repress the maternal 15q11-q13 region.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24760766      PMCID: PMC4481691          DOI: 10.1093/hmg/ddu187

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  42 in total

1.  The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A.

Authors:  M Runte; A Hüttenhofer; S Gross; M Kiefmann; B Horsthemke; K Buiting
Journal:  Hum Mol Genet       Date:  2001-11-01       Impact factor: 6.150

2.  Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes.

Authors:  Stormy J Chamberlain; Pin-Fang Chen; Khong Y Ng; Fany Bourgois-Rocha; Fouad Lemtiri-Chlieh; Eric S Levine; Marc Lalande
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

3.  SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state.

Authors:  Steve Bilodeau; Michael H Kagey; Garrett M Frampton; Peter B Rahl; Richard A Young
Journal:  Genes Dev       Date:  2009-11-01       Impact factor: 11.361

4.  Maternal methylation imprints on human chromosome 15 are established during or after fertilization.

Authors:  O El-Maarri; K Buiting; E G Peery; P M Kroisel; B Balaban; K Wagner; B Urman; J Heyd; C Lich; C I Brannan; J Walter; B Horsthemke
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

5.  Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome.

Authors:  F Muscatelli; D N Abrous; A Massacrier; I Boccaccio; M Le Moal; P Cau; H Cremer
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

6.  The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region.

Authors:  P Jay; C Rougeulle; A Massacrier; A Moncla; M G Mattei; P Malzac; N Roëckel; S Taviaux; J L Lefranc; P Cau; P Berta; M Lalande; F Muscatelli
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

7.  Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2.

Authors:  Claudia A Doege; Keiichi Inoue; Toru Yamashita; David B Rhee; Skylar Travis; Ryousuke Fujita; Paolo Guarnieri; Govind Bhagat; William B Vanti; Alan Shih; Ross L Levine; Sara Nik; Emily I Chen; Asa Abeliovich
Journal:  Nature       Date:  2012-08-30       Impact factor: 49.962

8.  ZNF274 recruits the histone methyltransferase SETDB1 to the 3' ends of ZNF genes.

Authors:  Seth Frietze; Henriette O'Geen; Kimberly R Blahnik; Victor X Jin; Peggy J Farnham
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

9.  Identification of a novel paternally expressed gene in the Prader-Willi syndrome region.

Authors:  R Wevrick; J A Kerns; U Francke
Journal:  Hum Mol Genet       Date:  1994-10       Impact factor: 6.150

10.  Characterization of the contradictory chromatin signatures at the 3' exons of zinc finger genes.

Authors:  Kimberly R Blahnik; Lei Dou; Lorigail Echipare; Sushma Iyengar; Henriette O'Geen; Erica Sanchez; Yongjun Zhao; Marco A Marra; Martin Hirst; Joseph F Costello; Ian Korf; Peggy J Farnham
Journal:  PLoS One       Date:  2011-02-15       Impact factor: 3.240

View more
  27 in total

Review 1.  Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update.

Authors:  Merlin G Butler; Jennifer L Miller; Janice L Forster
Journal:  Curr Pediatr Rev       Date:  2019

Review 2.  Transflammation: Innate immune signaling in nuclear reprogramming.

Authors:  Shu Meng; Palas Chanda; Rajarajan A Thandavarayan; John P Cooke
Journal:  Adv Drug Deliv Rev       Date:  2017-09-13       Impact factor: 15.470

Review 3.  Transflammation: How Innate Immune Activation and Free Radicals Drive Nuclear Reprogramming.

Authors:  Shu Meng; Palas Chanda; Rajarajan A Thandavarayan; John P Cooke
Journal:  Antioxid Redox Signal       Date:  2018-04-26       Impact factor: 8.401

Review 4.  Epigenetic therapy of Prader-Willi syndrome.

Authors:  Yuna Kim; Sung Eun Wang; Yong-Hui Jiang
Journal:  Transl Res       Date:  2019-03-05       Impact factor: 7.012

5.  Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome.

Authors:  Yuna Kim; Hyeong-Min Lee; Yan Xiong; Noah Sciaky; Samuel W Hulbert; Xinyu Cao; Jeffrey I Everitt; Jian Jin; Bryan L Roth; Yong-Hui Jiang
Journal:  Nat Med       Date:  2016-12-26       Impact factor: 53.440

Review 6.  Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches.

Authors:  Merlin G Butler; Ann M Manzardo; Janice L Forster
Journal:  Curr Pediatr Rev       Date:  2016

Review 7.  A practical guide to induced pluripotent stem cell research using patient samples.

Authors:  Katherine E Santostefano; Takashi Hamazaki; Nikolett M Biel; Shouguang Jin; Akihiro Umezawa; Naohiro Terada
Journal:  Lab Invest       Date:  2014-08-04       Impact factor: 5.662

8.  Specific ZNF274 binding interference at SNORD116 activates the maternal transcripts in Prader-Willi syndrome neurons.

Authors:  Maéva Langouët; Dea Gorka; Clarisse Orniacki; Clémence M Dupont-Thibert; Michael S Chung; Heather R Glatt-Deeley; Noelle Germain; Leann J Crandall; Justin L Cotney; Christopher E Stoddard; Marc Lalande; Stormy J Chamberlain
Journal:  Hum Mol Genet       Date:  2020-11-25       Impact factor: 6.150

Review 9.  Pluripotent stem cells in disease modelling and drug discovery.

Authors:  Yishai Avior; Ido Sagi; Nissim Benvenisty
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-28       Impact factor: 94.444

10.  The structure of the RbBP5 β-propeller domain reveals a surface with potential nucleic acid binding sites.

Authors:  Anshumali Mittal; Fruzsina Hobor; Ying Zhang; Stephen R Martin; Steven J Gamblin; Andres Ramos; Jon R Wilson
Journal:  Nucleic Acids Res       Date:  2018-04-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.